Ernst Brandt Selected Research

connective tissue-activating peptide (CTAP-III)

7/2004	Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
2/2002	The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ernst Brandt Research Topics

Disease

4	Infections 07/2010 - 07/2004
4	Inflammation (Inflammations) 07/2010 - 02/2002
2	Atherosclerosis 05/2007 - 03/2005
1	Neoplasms (Cancer) 07/2010
1	Hypersensitivity (Allergy) 07/2010
1	Peritonitis 08/2007
1	Sepsis (Septicemia) 08/2007
1	Abscess 07/2004
1	Escherichia coli Infections 07/2004

Drug/Important Bio-Agent (IBA)

3	ChemokinesIBA 07/2010 - 05/2007
2	connective tissue-activating peptide (CTAP-III)IBA 07/2004 - 02/2002
1	Platelet Factor 4IBA 12/2009
1	Macrophage Colony-Stimulating FactorIBA 12/2009
1	CathelicidinsIBA 08/2009
1	Tryptases (Tryptase)IBA 08/2009
1	SialyltransferasesIBA 06/2008
1	Peptide Hydrolases (Proteases)FDA Link 08/2007
1	Interleukin-15 (Interleukin 15)IBA 08/2007
1	Chymases (Chymase)IBA 08/2007
1	Transcription Factors (Transcription Factor)IBA 03/2005
1	Messenger RNA (mRNA)IBA 03/2005
1	Monomeric GTP-Binding ProteinsIBA 03/2005
1	Protein Isoforms (Isoforms)IBA 07/2004
1	CXC ChemokinesIBA 07/2004
1	Interleukin-8 (Interleukin 8)IBA 07/2004
1	Chelating AgentsIBA 07/2004
1	Chemotactic FactorsIBA 02/2002
1	Platelet Activating FactorIBA 02/2002
1	Complement System Proteins (Complement)IBA 02/2002

Therapy/Procedure

1	Punctures 08/2007
1	Ligation 08/2007
1	Gamma Cameras (Gamma Camera) 07/2004